Document is current
Any future updates will be listed below
-
Authors
Reindl, Caroline
Unger, Michaela
Walther, Katrin
Lang, Johannes D.
Gollwitzer, Stephanie
Cuny, Jeanne
Jenny, Stritzelberger
Welte, Tamara M.
Marterstock, Dominique C.
Doerfler, Arnd
Delev, Daniel
Rössler, Karl
Brandner, Sebastian
Rampp, Stefan
Schwab, Stefan
Lewczuk, Piotr
Hamer, Hajo M.
-
Funding
Funding for this research was provided by:
Universitätsklinikum Erlangen
- License Information
-
More Information
Article History
Received: 10 November 2024
Accepted: 26 February 2025
First Online: 7 March 2025
Declarations
:
: HMH has served on the scientific advisory board of Angelini, Corlieve, Eisai, GW/Jazz, Sandoz, UCB Pharma, UNEEG and UCB/Zogenix. He served on the speakers bureau of Ad-Tech, Alnylam, Angelini, Bracco, Desitin, Eisai, GW, Micromed, Nihon Kohden, Novartis, Pfizer, and UCB Pharma. JDL served on the speakers bureau of from Eisai and UCB Pharma. SR has served as adviser to Precisis GmbH. The remaining authors have no conflicts of interest.
: The study was approved by the Ethic committee by the Medical faculty of the Friedrich Alexander University Erlangen (IRB-No 65_20B). Participants gave informed consent to participate in the study before taking part.
: We confirm that we have read the Journal’s position on issues involved in ethical publication and affirm that this report is consistent with those guidelines.
